Attending this event?
Back To Schedule
Monday, September 19 • 4:30pm - 5:30pm
Panel: Fierce 15 - What does it mean to be Fierce?

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

In this panel, we check in with past Fierce 15 honorees to track their journeys from start-up to the big time. Where are they now, and where are they going?

avatar for Max Bayer

Max Bayer

Staff Writer, Fierce Biotech
Max Bayer is a staff writer for Fierce Biotech. He joined after more than three years at CBS News, two of which were spent covering the twists and turns of the COVID-19 pandemic, from infection trends to CDC guidelines. He graduated from the University of Wisconsin-Madison in 2018... Read More →

avatar for John Evans, MBA

John Evans, MBA

Chief Executive Officer and Board Member, Beam Therapeutics
John Evans joined Beam in 2017 as CEO, bringing significant experience as a company builder, dealmaker, and drug developer in the biotechnology industry.Mr. Evans was previously an early employee and member of the leadership team at Agios Pharmaceuticals, most recently serving as... Read More →
avatar for Fabrice Chouraqui, PharmD

Fabrice Chouraqui, PharmD

CEO, Cellarity
Fabrice Chouraqui, PharmD, joined Flagship Pioneering in 2020, where he serves as both CEO-Partner of Flagship Pioneering and CEO of Cellarity. Fabrice is an experienced global pharmaceutical executive with a passion for driving the progress of medical sciences and bringing innovation... Read More →
avatar for Thomas J. Schuetz, MD, PhD

Thomas J. Schuetz, MD, PhD

CEO, Compass Therapeutics
Thomas J. Schuetz, MD, PhD has over 20 years of experience in oncology, biopharmaceutical drug development and life science venture investing. He co-founded Compass in 2014 following conceptual discussions while he was a venture partner at OrbiMed. While at OrbiMed, Thomas also co-founded... Read More →
avatar for Andrew Allen, M.D., Ph.D.

Andrew Allen, M.D., Ph.D.

Co-founder, President and Chief Executive Officer, Gritstone bio
Andrew Allen, M.D., Ph.D. co-founded Gritstone bio, Inc. and has served as President, CEO and a board member since 2015. In 2009, Dr. Allen co-founded Clovis Oncology and served as Chief Medical Officer until 2015, driving development of Rucaparib, a PARP inhibitor. Prior he was Chief... Read More →

Monday September 19, 2022 4:30pm - 5:30pm EDT